Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro does not directly trigger a period. There is no mechanism in tirzepatide that switches on menstruation, and the medicine carries no licensed indication relating to the menstrual cycle. What does happen (and what many women notice) is that significant weight loss can restore hormonal patterns that had been disrupted by excess weight, and a period that had gone missing may return as a result. The medicine is a prescription-only treatment requiring clinical assessment before anyone is prescribed it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people who ask this question have heard that Mounjaro can "restart" a period and wonder whether the medicine itself is doing something hormonal. It is not. Tirzepatide is a dual GIP and GLP-1 receptor agonist, it works on receptors involved in appetite regulation and blood-sugar control, and it slows gastric emptying to increase fullness. There are no oestrogen, progesterone or androgen components. The NHS tirzepatide medicines page lists the known mechanisms and side effects; menstruation is not among them.
So if Mounjaro does not act on the cycle directly, why do some women find their periods returning? The answer lies almost entirely in what weight loss does to the body's hormonal environment, and that is where the real explanation sits.
It is worth being honest about what we do not yet know. Long-term, large-scale data on menstrual outcomes during tirzepatide treatment does not yet exist. The SURMOUNT-1 trial, published in the New England Journal of Medicine, was not designed to track cycle changes. Clinicians are working from established endocrinology about weight and hormones, applied to a new medicine's effects.
Adipose tissue (body fat) is metabolically active. It produces and stores oestrogen, and in higher amounts it can disrupt the delicate hormonal signalling between the brain, the pituitary gland and the ovaries. For some women, particularly those living with obesity or PCOS, this disruption suppresses ovulation or makes cycles irregular and unpredictable.
When weight falls, that hormonal environment shifts. Insulin sensitivity often improves, which matters because high insulin levels drive excess androgen production in the ovaries, a central mechanism in PCOS-related cycle disruption. As androgens come down and oestrogen signalling normalises, the hypothalamic-pituitary-ovarian axis can begin to function more regularly. A period that had not appeared for months, or had been erratic for years, may return.
This is well-established physiology, not specific to Mounjaro. It has been observed with any intervention that produces meaningful weight loss, including dietary changes and bariatric surgery. Mounjaro produces substantial average weight loss in clinical trials (around 20% at the highest dose over 72 weeks) and for women whose cycles were weight-dependent, the hormonal downstream effects can follow. Our page on how Mounjaro can change your period covers the broader range of cycle changes women report.
A question our prescribers hear most weeks is some version of: "My period came back after starting Mounjaro, is that normal?" The short answer is that it is not medically surprising, but it does carry a practical implication that many people miss.
If your period returns and you are sexually active, you may now be ovulating, possibly for the first time in months or years. That means the standard contraception caution applies with extra urgency. For women on oral contraceptives, there is a specific interaction to be aware of: tirzepatide slows gastric emptying, which can reduce absorption of the contraceptive pill, particularly during the first four weeks of treatment and in the four weeks after each dose increase. NHS guidance recommends adding a non-oral method of contraception during those windows. Our page on whether Mounjaro can make your period late addresses that timing question in more detail.
Hypothalamic amenorrhoea (periods stopping because the brain down-regulates reproductive function, often linked to low energy availability or high stress as well as weight) can also respond to weight restoration or metabolic improvement. If you are unsure whether Mounjaro can affect your period in ways beyond what weight loss alone would explain, discussing this with your GP before attributing the change entirely to the treatment is sensible. There may be other causes worth ruling out.
Not every change in your period during Mounjaro treatment is straightforwardly explained by the above. Heavy, prolonged or very painful bleeding that starts or worsens after beginning treatment should be assessed by a GP. If you are wondering whether Mounjaro can stop your period, that is also worth raising with a clinician, as these are not expected effects of tirzepatide or weight loss.
If you are considering Mounjaro and have questions about taking Mounjaro on your period, or how it might interact with an existing gynaecological condition or your contraception, those questions are best answered before you start treatment rather than after. At nume, a real prescriber reviews every consultation, your specific history is read and considered, not processed by a form. You can read more about Mounjaro and how it works, or explore weight-loss treatment options more broadly, before deciding whether to take the next step.
If you are ready to discuss your circumstances with a clinician, speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.